Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 22:11:7981-7989.
doi: 10.2147/CMAR.S219237. eCollection 2019.

The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma

Manni Wang  1 , Shuang Wu  1 , An Tong  1 , Xiwei Cui  1 , Xuelei Ma  1
Affiliations

The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma

Manni Wang et al. Cancer Manag Res. .

Abstract

Background: Recent studies have suggested a significant relationship between inflammatory indexes such as the neutrophil-to-lymphocyte ratio (NLR) and survival outcomes in various cancers. The aim of the present study was to evaluate the prognostic value of 6 pretreatment inflammatory markers in patients with primary angiosarcoma (AS) which is a rare and highly malignant type of soft tissue sarcoma.

Methods: Fifty-six patients diagnosed with primary AS at West China Hospital between August 2009 and July 2016 were retrospectively enrolled. The value of each biomarker was calculated for its correlation with patients' overall survival.

Results: The low tumor grade, tumor size <5 cm, metastatic status, surgical treatment and low level of monocyte-to-lymphocyte ratio, NLR and lactate dehydrogenase (LDH) were correlated with better survival outcome in univariate analyses. In multivariate analyses, high levels of NLR (HR 2.673, 95% CI 1.253-5.703, p=0.011) and LDH (HR 2.964, 95% CI 1.464-5.998, p=0.003) were selected as independent prognostic factors.

Conclusion: This study identifies the elevated pretreatment levels of NLR and LDH as prognostic markers in patients with primary AS.

Keywords: angiosarcoma; inflammatory biomarker; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
ROC of NLR, PLR, MLR, SII, LDH and ALP for patients’ overall survival. Abbreviations: NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; SII, systemic immune-inflammation index; LDH, lactate dehydrogenase; ROC, receiver operating curve.
Figure 2
Figure 2
Kaplan–Meier curves comparing overall survival in patients with different clinicopathological features and marker levels: (A) tumor grade; (B) tumor size; (C) metastatic vs nonmetastatic patients; (D) surgery or no surgery; (E) low vs high; (F) low vs high; (G) low vs high. Abbreviations: NLR, neutrophil-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; LDH, lactate dehydrogenase.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Rouhani P, Fletcher CD, Devesa SS, Toro JR. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases. Cancer. 2008;113(3):616–627. doi:10.1002/cncr.23571 - DOI - PubMed
    1. Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer. 2006;119(12):2922–2930. doi:10.1002/ijc.22239 - DOI - PubMed
    1. Wang L, Lao IW, Yu L, Wang J. Clinicopathological features and prognostic factors in angiosarcoma: a retrospective analysis of 200 patients from a single Chinese medical institute. Oncol Lett. 2017;14(5):5370–5378. doi:10.3892/ol.2017.6892 - DOI - PMC - PubMed
    1. Fayette J, Martin E, Piperno-Neumann S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18(12):2030–2036. - PubMed
    1. Shin JY, Roh SG, Lee NH, Yang KM. Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis. Head Neck. 2017;39(2):380–386. - PubMed